Li Kang Biomedical Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	83.82	77.02	110.99	112.09	51.44
Depreciation & Amortization	8.79	12.43	11.74	10.99	12.89
Loss (Gain) From Sale of Investments	0.46	-0.28	-0.9	2.2	1.75
Stock-Based Compensation	-	4.64	-	-	-
Other Operating Activities	-4.1	-29.45	-5.4	13.2	-8.71
Change in Accounts Receivable	0.18	-0.25	0.92	-2.15	-0.59
Change in Inventory	-0.7	-3.66	-8.79	-4.25	2.64
Change in Accounts Payable	-1.07	4.57	-8	3.76	8.18
Change in Other Net Operating Assets	4.76	0.35	-3.82	21.41	-7.16
Operating Cash Flow	92.15	65.38	96.74	157.24	60.45
Operating Cash Flow Growth	40.94%	-32.42%	-38.48%	160.14%	-25.98%
Capital Expenditures	-329.38	-62.75	-3.26	-1.16	-4.25
Sale (Purchase) of Intangibles	-0.17	-1.98	-	-1.54	-0.2
Investment in Securities	241.24	-199.54	-62.01	-58.33	14.44
Other Investing Activities	4.74	6.5	3.43	1.41	2.21
Investing Cash Flow	-83.57	-257.76	-61.84	-59.62	12.2
Short-Term Debt Issued	120	24	12	-	-
Long-Term Debt Issued	-	35	35	-	-
Total Debt Issued	120	59	47	-	-
Short-Term Debt Repaid	-50	-24	-12	-	-
Long-Term Debt Repaid	-36.98	-35	-43.48	-33.47	-7.52
Total Debt Repaid	-86.98	-59	-55.48	-33.47	-7.52
Net Debt Issued (Repaid)	33.02	-	-8.48	-33.47	-7.52
Issuance of Common Stock	-	225	-	-	-
Common Dividends Paid	-63.61	-79.52	-46.62	-33.3	-62.16
Other Financing Activities	-	-	0.02	-0.2	0.29
Financing Cash Flow	-30.6	145.48	-55.07	-66.97	-69.39
Net Cash Flow	-22.02	-46.9	-20.17	30.65	3.26
Free Cash Flow	-237.23	2.63	93.48	156.08	56.19
Free Cash Flow Growth	-	-97.19%	-40.11%	177.77%	-29.67%
Free Cash Flow Margin	-40.26%	0.46%	14.85%	22.81%	14.52%
Free Cash Flow Per Share	-7.42	0.08	3.47	5.79	2.09
Cash Interest Paid	0.37	0.25	0.62	0.32	0.42
Cash Income Tax Paid	18.08	43.33	28.53	12.06	17.79
Levered Free Cash Flow	-256.22	-13.73	70.08	127.73	40.35
Unlevered Free Cash Flow	-255.98	-13.3	70.47	127.91	40.64
Change in Working Capital	3.17	1.02	-19.69	18.76	3.07

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.